NM_000567.3:c.*216C>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000567.3(CRP):c.*216C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0261 in 524,840 control chromosomes in the GnomAD database, including 1,406 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.066 ( 1099 hom., cov: 31)
Exomes 𝑓: 0.0098 ( 307 hom. )
Consequence
CRP
NM_000567.3 3_prime_UTR
NM_000567.3 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.539
Publications
18 publications found
Genes affected
CRP (HGNC:2367): (C-reactive protein) The protein encoded by this gene belongs to the pentraxin family which also includes serum amyloid P component protein and pentraxin 3. Pentraxins are involved in complement activation and amplification via communication with complement initiation pattern recognition molecules, but also complement regulation via recruitment of complement regulators. The encoded protein has a calcium dependent ligand binding domain with a distinctive flattened beta-jellyroll structure. It exists in two forms as either a pentamer in circulation or as a nonsoluble monomer in tissues. It is involved in several host defense related functions based on its ability to recognize foreign pathogens and damaged cells of the host and to initiate their elimination by interacting with humoral and cellular effector systems in the blood. Consequently, the level of this protein in plasma increases greatly during acute phase response to tissue injury, infection, or other inflammatory stimuli. Elevated expression of the encoded protein is associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. [provided by RefSeq, Aug 2020]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.224 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CRP | NM_000567.3 | c.*216C>A | 3_prime_UTR_variant | Exon 2 of 2 | ENST00000255030.9 | NP_000558.2 | ||
| CRP | NM_001382703.1 | c.*216C>A | 3_prime_UTR_variant | Exon 3 of 3 | NP_001369632.1 | |||
| CRP | NM_001329057.2 | c.*22+194C>A | intron_variant | Intron 2 of 2 | NP_001315986.1 | |||
| CRP | NM_001329058.2 | c.*22+194C>A | intron_variant | Intron 3 of 3 | NP_001315987.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CRP | ENST00000255030.9 | c.*216C>A | 3_prime_UTR_variant | Exon 2 of 2 | 1 | NM_000567.3 | ENSP00000255030.5 |
Frequencies
GnomAD3 genomes AF: 0.0657 AC: 9989AN: 152056Hom.: 1089 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
9989
AN:
152056
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00981 AC: 3654AN: 372666Hom.: 307 Cov.: 5 AF XY: 0.00844 AC XY: 1614AN XY: 191218 show subpopulations
GnomAD4 exome
AF:
AC:
3654
AN:
372666
Hom.:
Cov.:
5
AF XY:
AC XY:
1614
AN XY:
191218
show subpopulations
African (AFR)
AF:
AC:
2537
AN:
11346
American (AMR)
AF:
AC:
209
AN:
12908
Ashkenazi Jewish (ASJ)
AF:
AC:
44
AN:
11770
East Asian (EAS)
AF:
AC:
0
AN:
28096
South Asian (SAS)
AF:
AC:
34
AN:
21434
European-Finnish (FIN)
AF:
AC:
1
AN:
24914
Middle Eastern (MID)
AF:
AC:
77
AN:
1690
European-Non Finnish (NFE)
AF:
AC:
253
AN:
237970
Other (OTH)
AF:
AC:
499
AN:
22538
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
144
288
432
576
720
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0659 AC: 10029AN: 152174Hom.: 1099 Cov.: 31 AF XY: 0.0639 AC XY: 4757AN XY: 74394 show subpopulations
GnomAD4 genome
AF:
AC:
10029
AN:
152174
Hom.:
Cov.:
31
AF XY:
AC XY:
4757
AN XY:
74394
show subpopulations
African (AFR)
AF:
AC:
9442
AN:
41456
American (AMR)
AF:
AC:
355
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
18
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5172
South Asian (SAS)
AF:
AC:
9
AN:
4826
European-Finnish (FIN)
AF:
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
AC:
91
AN:
68016
Other (OTH)
AF:
AC:
96
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
384
768
1152
1536
1920
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
92
184
276
368
460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
74
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.